Normalcy of Food Intake in Head and Neck Cancer Patients (FOCISD)
Normalcy of Food Intake in Head and Neck Cancer Patients Receiving (Chemo)Radiotherapy Supported by Swallowing Therapy and Individual Dietary Counselling. (Supportive Care)
Sponsor: Fresenius Kabi Nederland BV
Listed as NCT01110980, this NA trial focuses on Neoplasms, Head and Neck and remains completed. Sponsored by Fresenius Kabi Nederland BV, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fresenius Kabi Nederland BV
- Radboud University Medical Center
- Sorgente BV
For direct contact, visit the study record on ClinicalTrials.gov .